| Year |
Citation |
Score |
| 2023 |
Dafun AS, Živković D, Leon-Icaza SA, Möller S, Froment C, Bonnet D, de Jesus AA, Alric L, Quaranta-Nicaise M, Ferrand A, Cougoule C, Meunier E, Burlet-Schiltz O, Ebstein F, Goldbach-Mansky R, et al. Establishing 20S Proteasome Genetic, Translational and Post-Translational Status from Precious Biological and Patient Samples with Top-Down MS. Cells. 12. PMID 36980185 DOI: 10.3390/cells12060844 |
0.584 |
|
| 2022 |
Izopet J, Kamar N, Abravanel F, Dubois M, Lhomme S, Mansuy JM, Alric L, Peron JM, Rostaing L. [Chronic hepatitis E virus infection]. Virologie (Montrouge, France). 13: 317-325. PMID 36151664 DOI: 10.1684/13-6.2011.13919 |
0.313 |
|
| 2022 |
Rahabi M, Salon M, Bruno-Bonnet C, Prat M, Jacquemin G, Benmoussa K, Alaeddine M, Parny M, Bernad J, Bertrand B, Auffret Y, Robert-Jolimaître P, Alric L, Authier H, Coste A. Bioactive fish collagen peptides weaken intestinal inflammation by orienting colonic macrophages phenotype through mannose receptor activation. European Journal of Nutrition. PMID 34999930 DOI: 10.1007/s00394-021-02787-7 |
0.753 |
|
| 2020 |
Tan BK, Chalouni M, Ceron DS, Cinaud A, Esterle L, Loko MA, Katlama C, Poizot-Martin I, Neau D, Chas J, Morlat P, Rosenthal E, Lacombe K, Naqvi A, Barange K, ... ... Alric L, et al. Atherosclerotic Cardiovascular Events in Patients Infected With Human Immunodeficiency Virus and Hepatitis C Virus. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32686834 DOI: 10.1093/Cid/Ciaa1014 |
0.4 |
|
| 2020 |
Audureau E, Carrat F, Layese R, Cagnot C, Asselah T, Guyader D, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, Riachi G, ... ... Alric L, et al. Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status. Journal of Hepatology. PMID 32615276 DOI: 10.1016/J.Jhep.2020.05.052 |
0.308 |
|
| 2020 |
Rahabi M, Jacquemin G, Prat M, Meunier E, AlaEddine M, Bertrand B, Lefèvre L, Benmoussa K, Batigne P, Aubouy A, Auwerx J, Kirzin S, Bonnet D, Danjoux M, Pipy B, ... Alric L, et al. Divergent Roles for Macrophage C-type Lectin Receptors, Dectin-1 and Mannose Receptors, in the Intestinal Inflammatory Response. Cell Reports. 30: 4386-4398.e5. PMID 32234475 DOI: 10.1016/J.Celrep.2020.03.018 |
0.737 |
|
| 2019 |
Abravanel F, Lhomme S, Trémeaux P, Migueres M, Harter A, Haslé C, Bruel P, Alric L, Métivier S, Raymond S, Izopet J. Performance of the Xpert HBV Viral Load assay versus the Aptima Quant assay for quantifying hepatitis B virus DNA. Diagnostic Microbiology and Infectious Disease. 114946. PMID 31771903 DOI: 10.1016/J.Diagmicrobio.2019.114946 |
0.306 |
|
| 2019 |
Asselah T, Pol S, Hezode C, Loustaud-Ratti V, Leroy V, Ahmed SNS, Ozenne V, Bronowicki JP, Larrey D, Tran A, Alric L, Nguyen-Khac E, Robertson MN, Hanna GJ, Brown D, et al. Efficacy and safety of elbasvir/grazoprevir for 8 or 12 weeks for hepatitis C virus: genotype 4 infection: a randomized study. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 31765046 DOI: 10.1111/Liv.14313 |
0.416 |
|
| 2019 |
Protin C, Abravanel F, Alric L, Tavitian S, Obéric L, Izopet J, Martin-Blondel G, Ysebaert L. Ribavirin for Chronic Hepatitis E Virus Infection in Ibrutinib-Exposed Patients. Open Forum Infectious Diseases. 6: ofz345. PMID 31660412 DOI: 10.1093/Ofid/Ofz345 |
0.392 |
|
| 2019 |
von Felden J, Alric L, Pischke S, Aitken C, Schlabe S, Spengler U, Teresa Giordani M, Schnitzler P, Bettinger D, Thimme R, Xhaard A, Binder M, Ayuk F, Lohse AW, Cornelissen JJ, et al. The Burden of Hepatitis E among Patients with Hematological Malignancies: a Retrospective European Cohort Study. Journal of Hepatology. PMID 31108159 DOI: 10.1016/J.Jhep.2019.04.022 |
0.393 |
|
| 2019 |
Chalouni M, Sogni P, Miailhes P, Lacombe K, Poizot-Martin I, Chas J, Vittecoq D, Neau D, Aumaitre H, Alric L, Piroth L, Bouchaud O, Katlama C, Morlat P, Lascoux-Combe C, et al. Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort. European Journal of Gastroenterology & Hepatology. PMID 31033848 DOI: 10.1097/Meg.0000000000001408 |
0.414 |
|
| 2019 |
Del Bello A, Abravanel F, Alric L, Lavayssiere L, Lhomme S, Bellière J, Izopet J, Kamar N. No evidence of occult hepatitis C or E virus infections in liver-transplant patients with sustained virological response after therapy with direct acting agents. Transplant Infectious Disease : An Official Journal of the Transplantation Society. e13093. PMID 30972874 DOI: 10.1111/Tid.13093 |
0.449 |
|
| 2019 |
Hedskog C, Parhy B, Chang S, Zeuzem S, Moreno C, Shafran SD, Borgia SM, Asselah T, Alric L, Abergel A, Chen JJ, Collier J, Kapoor D, Hyland RH, Simmonds P, et al. Identification of 19 Novel Hepatitis C Virus Subtypes-Further Expanding HCV Classification. Open Forum Infectious Diseases. 6: ofz076. PMID 30949527 DOI: 10.1093/Ofid/Ofz076 |
0.411 |
|
| 2019 |
Laurain A, Metivier S, Haour G, Larrey D, Dorival C, Hezode C, Zoulim F, Marcellin P, Bourliere M, Zarski JP, Thabut D, Alric L, Ganne-Carrie N, Cales P, Bronowicki JP, et al. Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohort. Bmc Infectious Diseases. 19: 300. PMID 30940090 DOI: 10.1186/S12879-019-3923-5 |
0.368 |
|
| 2019 |
Fontaine H, Alric L, Labreuche J, Legendre B, Louvet A, Antoine C, Legendre CM, Hazzan M, Kamar N, Dharancy S, Pol S, Duhamel A, Mathurin P. Control of replication of hepatitis B and C virus improves patient and graft survival in kidney transplantation. Journal of Hepatology. PMID 30879789 DOI: 10.1016/J.Jhep.2018.12.036 |
0.435 |
|
| 2019 |
Thabut D, Bureau C, Layese R, Bourcier V, Hammouche M, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, ... ... Alric L, et al. Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy. Gastroenterology. PMID 30768988 DOI: 10.1053/J.Gastro.2018.11.053 |
0.415 |
|
| 2019 |
Carrat F, Fontaine H, Dorival C, Simony M, Diallo A, Hezode C, De Ledinghen V, Larrey D, Haour G, Bronowicki JP, Zoulim F, Asselah T, Marcellin P, Thabut D, Leroy V, ... ... Alric L, et al. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study. Lancet (London, England). PMID 30765123 DOI: 10.1016/S0140-6736(18)32111-1 |
0.441 |
|
| 2019 |
Shili-Masmoudi S, Sogni P, de Ledinghen V, Esterle L, Valantin MA, Poizot-Martin I, Simon A, Rosenthal E, Lacombe K, Pialoux G, Bouchaud O, Gervais-Hasenknoff A, Goujard C, Piroth L, Zucman D, ... ... Alric L, et al. Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study. Plos One. 14: e0211286. PMID 30682180 DOI: 10.1371/Journal.Pone.0211286 |
0.319 |
|
| 2019 |
Alaeddine M, Prat M, Poinsot VH, Gouazé-Andersson V, Authier H, Meunier E, Lefèvre L, Alric C, Dardenne C, Bernad J, Alric L, Ségui B, Balard P, Couderc F, Couderc B, et al. IL13-mediated dectin-1 and mannose receptor overexpression promotes macrophage antitumor activities through recognition of sialylated tumor cells. Cancer Immunology Research. PMID 30610060 DOI: 10.1158/2326-6066.Cir-18-0213 |
0.711 |
|
| 2019 |
Dion J, Malphettes M, Bénéjat L, Mégraud F, Wargnier A, Boutboul D, Galicier L, Moing VL, Giraud P, Jaccard A, Nove-Josserand R, Fieschi C, Oksenhendler E, Gérard L, Oksenhendler E, ... ... Alric L, et al. Campylobacter infection in adult patients with primary antibody deficiency. The Journal of Allergy and Clinical Immunology: in Practice. 7: 1038. PMID 29981862 DOI: 10.1016/J.Jaip.2018.06.014 |
0.344 |
|
| 2019 |
Meunier L, Pageaux G, Radenne S, Pichard AV, Houssel-Debry P, Duvoux C, Fridlund DB, Ledinghen VD, Conti F, Anty R, Martino VD, Gratien M, Leroy V, Lebray P, Alric L, et al. SAT-248-Patients treated for HCV and listed for LT in a French multicenter study: What happens at 3 years? Journal of Hepatology. 70: e741-e742. DOI: 10.1016/S0618-8278(19)31481-1 |
0.384 |
|
| 2018 |
Vergara C, Thio CL, Johnson E, Kral AH, O'Brien TR, Goedert JJ, Mangia A, Piazzolla V, Mehta SH, Kirk GD, Kim AY, Lauer GM, Chung RT, Cox AL, Peters MG, ... ... Alric L, et al. Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus. Gastroenterology. PMID 30593799 DOI: 10.1053/J.Gastro.2018.12.014 |
0.406 |
|
| 2018 |
Poizot-Martin I, Rosenthal E, Gilbert C, Cano CE, Simon A, Lascoux-Combe C, Alric L, Gervais A, Neau D, Esterle L, Salmon D, Sogni P, Wittkop L. Nadir CD4 is negatively associated with antinuclear antibody detection in HCV/HIV coinfected patients. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 30570526 DOI: 10.1097/Qai.0000000000001940 |
0.35 |
|
| 2018 |
Billa O, Chalouni M, Salmon D, Poizot-Martin I, Gilbert C, Katlama C, Neau D, Chas J, Morlat P, Lacombe K, Naqvi A, Barange K, Gervais A, Bouchaud O, Rosenthal E, ... ... Alric L, et al. Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort. Plos One. 13: e0208657. PMID 30562358 DOI: 10.1371/Journal.Pone.0208657 |
0.381 |
|
| 2018 |
Merli M, Frigeni M, Alric L, Visco C, Besson C, Mannelli L, Di Rocco A, Ferrari A, Farina L, Pirisi M, Piazza F, Loustaud-Ratti V, Arcari A, Marino D, Sica A, et al. Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas. The Oncologist. PMID 30552159 DOI: 10.1634/Theoncologist.2018-0331 |
0.392 |
|
| 2018 |
Brichler S, Nahon P, Zoulim F, Layese R, Bourcier V, Audureau E, Sutton A, Letouze E, Cagnot C, Marcellin P, Guyader D, Roulot D, Pol S, de Ledinghen V, Zarski JP, ... ... Alric L, et al. Non-virological factors are drivers of Hepatocellular Carcinoma in virosuppressed Hepatitis B cirrhosis: results of ANRS CO12 CirVir cohort. Journal of Viral Hepatitis. PMID 30380181 DOI: 10.1111/Jvh.13029 |
0.326 |
|
| 2018 |
Abravanel F, Lacipière A, Lhomme S, Dubois M, Minier L, Peron JM, Alric L, Kamar N, Izopet J. Performance of a commercial assay for detecting and quantifying HEV RNA in faeces. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 109: 1-5. PMID 30336371 DOI: 10.1016/J.Jcv.2018.10.003 |
0.321 |
|
| 2018 |
Nahon P, Layese R, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, ... ... Alric L, et al. Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs. Gastroenterology. PMID 30031138 DOI: 10.1053/J.Gastro.2018.07.015 |
0.388 |
|
| 2018 |
Cacoub P, Si Ahmed SN, Ferfar Y, Pol S, Thabut D, Hezode C, Alric L, Comarmond C, Ragab G, Quartuccio L, Hegazy M, Poynard T, Rigon MR, Saadoun D. Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus-Associated Cryoglobulinemia Vasculitis. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 29857143 DOI: 10.1016/J.Cgh.2018.05.021 |
0.408 |
|
| 2018 |
Marion O, Abravanel F, Bello AD, Esposito L, Lhomme S, Puissant-Lubrano B, Alric L, Faguer S, Izopet J, Kamar N. Hepatitis E virus-associated cryoglobulinemia in solid-organ-transplant recipients. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 29845733 DOI: 10.1111/Liv.13894 |
0.343 |
|
| 2018 |
Girard M, Poujois A, Fabre M, Lacaille F, Debray D, Rio M, Fenaille F, Cholet S, Ruel C, Caussé E, Selves J, Bridoux-Henno L, Woimant F, Dupré T, Vuillaumier-Barrot S, ... ... Alric L, et al. CCDC115-CDG: A new rare and misleading inherited cause of liver disease. Molecular Genetics and Metabolism. PMID 29759592 DOI: 10.1016/J.Ymgme.2018.05.002 |
0.305 |
|
| 2018 |
Alric L, Ollivier-Hourmand I, Bérard E, Hillaire S, Guillaume M, Vallet-Pichard A, Bernard-Chabert B, Loustaud-Ratti V, Bourlière M, de Ledinghen V, Fouchard-Hubert I, Canva V, Minello A, Nguyen-Khac E, Leroy V, et al. Grazoprevir plus elbasvir in HCV genotype-1 or -4 infected patients with stage 4/5 severe chronic kidney disease is safe and effective. Kidney International. PMID 29735308 DOI: 10.1016/J.Kint.2018.02.019 |
0.4 |
|
| 2018 |
Costentin C, Layese R, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, ... ... Alric L, et al. Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-time Adjusted Survival of Patients With Compensated Viral Cirrhosis. Gastroenterology. PMID 29729258 DOI: 10.1053/J.Gastro.2018.04.027 |
0.327 |
|
| 2018 |
Allaire M, Cadranel JD, Bureau C, Zerkly S, Thévenot T, Garioud A, Cacoub P, Macaigne G, Alric L, Jouannaud V, Lison H, Chagneau-Derrode C, Pariente A, Pe Combining Acute Accent Laquier ACGAS, Bourlie Combining Grave Accent Re M, et al. Severe liver failure rather than cirrhosis is associated with mortality in patients with infectious endocarditis: a retrospective case-control study. European Journal of Gastroenterology & Hepatology. PMID 29727379 DOI: 10.1097/Meg.0000000000001155 |
0.31 |
|
| 2018 |
Allaire M, Nahon P, Layese R, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, ... ... Alric L, et al. Extra hepatic cancers are the leading cause of death in cirrhotic patients achieving HBV control or HCV eradication. Hepatology (Baltimore, Md.). PMID 29663511 DOI: 10.1002/Hep.30034 |
0.373 |
|
| 2018 |
Cacoub P, Nahon P, Layese R, Blaise L, Desbois AC, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, ... ... Alric L, et al. Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients. American Heart Journal. 198: 4-17. PMID 29653647 DOI: 10.1016/J.Ahj.2017.10.024 |
0.425 |
|
| 2018 |
Pol S, Marion O, Vallet-Pichard A, Meritet JF, Sauné K, Alric L, Kamar N. Direct-acting antivirals and hepatitis B virus (HBV) reactivation in co-infected HBV/HCV kidney-transplant recipients. Transplant Infectious Disease : An Official Journal of the Transplantation Society. PMID 29512231 DOI: 10.1111/Tid.12864 |
0.423 |
|
| 2018 |
Cacoub P, ahmed SNS, ferfar Y, Pol S, Thabut D, Hezode C, Alric L, Comarmond C, Ragab G, Quatuccio L, Hegazy M, Poynard T, Rigon MR, Saadoun D. OP0235 Interferon-free antivirals for hepatitis c virus-associated cryoglobulinemia vasculitis: a long-term follow-up study Annals of the Rheumatic Diseases. 77: 167-167. DOI: 10.1136/Annrheumdis-2018-Eular.2324 |
0.402 |
|
| 2018 |
Ledinghen V, Anne V, Jose U, Lucia P, Jean-Baptiste H, Giovanna S, Wassil M, Pageaux G, Helene F, Alric L, Hezode C. Sofosbuvir + Glecaprevir/Pibrentasvir in patients with difficult to treat HCV infection. Final results of the French compassionate use Journal of Hepatology. 68: S259. DOI: 10.1016/S0168-8278(18)30732-3 |
0.401 |
|
| 2018 |
Asselah T, Pol S, Hezode C, Loustaud-Ratti V, Leroy V, Ahmed S, Ozenne V, Bronowicki J, Larrey D, Tran A, Alric L, Nguyen-Khac E, Robertson M, Hanna G, Brown D, et al. Efficacy and safety of 8 weeks of elbasvir/grazoprevir in HCV GT4-infected treatment-naīve participants Journal of Hepatology. 68: S3-S4. DOI: 10.1016/S0168-8278(18)30225-3 |
0.359 |
|
| 2018 |
de Ledinghen V, Varaut A, Ursic-Bedoya J, Parlati L, Hiriart J, Scoazec G, Merrouche W, Pageaux G, Fontaine H, Alric L, Hezode C. 719 - Sofosbuvir + Glecaprevir/Pibrentasvir (G/P) in Patients with Difficult to Treat HCV Infection. Final Results of the French Compassionate Use Gastroenterology. 154: S-1104. DOI: 10.1016/S0016-5085(18)33671-0 |
0.386 |
|
| 2017 |
Huang H, Duggal P, Thio CL, Latanich R, Goedert JJ, Mangia A, Cox AL, Kirk GD, Mehta S, Aneja J, Alric L, Donfield SM, Cramp ME, Khakoo SI, Tobler LH, et al. Fine-mapping of genetic loci driving spontaneous clearance of hepatitis C virus infection. Scientific Reports. 7: 15843. PMID 29158528 DOI: 10.1038/S41598-017-16011-2 |
0.385 |
|
| 2017 |
de Lédinghen V, Laforest C, Hézode C, Pol S, Renault A, Alric L, Larrey D, Métivier S, Tran A, Jézéquel C, Samuel D, Zoulim F, Tual C, Pailhé A, Gibowski S, et al. Retreatment with sofosbuvir plus grazoprevir/elbasvir plus ribavirin of patients with hepatitis C virus genotype 1 or 4 who previously failed a NS5A or NS3-containing regimen. ANRS HC34 REVENGE. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29077864 DOI: 10.1093/Cid/Cix916 |
0.435 |
|
| 2017 |
Halfon P, Scholtès C, Izopet J, Larrat S, Trimoulet P, Zoulim F, Alric L, Métivier S, Leroy V, Ouzan D, de Lédinghen V, Mohamed S, Pénaranda G, Khiri H, Thélu MA, et al. Retreatment with direct-acting antivirals of genotypes 1-3-4 hepatitis C patients who failed an anti-NS5A regimen in real world. Journal of Hepatology. PMID 28987520 DOI: 10.1016/J.Jhep.2017.09.019 |
0.36 |
|
| 2017 |
Wyles D, Poordad F, Wang S, Alric L, Felizarta F, Kwo PY, Maliakkal B, Agarwal K, Hassanein T, Weilert F, Lee SS, Kort J, Lovell SS, Liu R, Lin CW, et al. Glecaprevir/Pibrentasvir for HCV Genotype 3 Patients with Cirrhosis and/or Prior Treatment Experience: A Partially Randomized Phase III Clinical Trial. Hepatology (Baltimore, Md.). PMID 28926120 DOI: 10.1002/Hep.29541 |
0.423 |
|
| 2017 |
Halfon P, Scholtès C, Izopet J, Larrat S, Trimoulet P, Zoulim F, Alric L, Métivier S, Leroy V, Ouzan D, de Lédinghen V, Mohamed S, Pénaranda G, Khiri H, Thélu MA, et al. Baseline and post-treatment hepatitis C NS5A resistance in relapsed patients from a multicentric real-life cohort. Antiviral Therapy. PMID 28730994 DOI: 10.3851/Imp3184 |
0.352 |
|
| 2017 |
Bourlière M, Rabiega P, Ganne-Carrie N, Serfaty L, Marcellin P, Barthe Y, Thabut D, Guyader D, Hezode C, Picon M, Causse X, Leroy V, Bronowicki JP, Carrieri P, Riachi G, ... ... Alric L, et al. Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial. The Lancet. Gastroenterology & Hepatology. 2: 177-188. PMID 28404133 DOI: 10.1016/S2468-1253(16)30189-3 |
0.355 |
|
| 2017 |
Saadoun D, Pol S, Ferfar Y, Alric L, Hezode C, Si Ahmed SN, de Saint Martin L, Comarmond C, Bouyer AS, Musset L, Poynard T, Resche Rigon M, Cacoub P. Efficacy and Safety of Sofosbuvir plus Daclatasvir for Treatment of HCV-associated Cryoglobulinemia Vasculitis. Gastroenterology. PMID 28288791 DOI: 10.1053/J.Gastro.2017.03.006 |
0.422 |
|
| 2017 |
Comarmond C, Garrido M, Pol S, Desbois AC, Costopoulos M, Le Garff-Tavernier M, Si Ahmed SN, Alric L, Fontaine H, Bellier B, Maciejewski A, Rosenzwajg M, Klatzmann D, Musset L, Poynard T, et al. Direct-acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-induced Cryoglobulinemia Vasculitis. Gastroenterology. PMID 28274850 DOI: 10.1053/J.Gastro.2017.02.037 |
0.428 |
|
| 2017 |
Piroth L, Wittkop L, Lacombe K, Rosenthal E, Gilbert C, Miailhes P, Carrieri P, Chas J, Poizot-Martin I, Gervais A, Dominguez S, Neau D, Zucman D, Billaud E, Morlat P, ... ... Alric L, et al. Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-coinfected patients - French ANRS CO13 HEPAVIH cohort. Journal of Hepatology. PMID 28235612 DOI: 10.1016/J.Jhep.2017.02.012 |
0.355 |
|
| 2017 |
Zhou X, Huang F, Xu L, Lin Z, de Vrij FM, Ayo-Martin AC, van der Kroeg M, Zhao M, Yin Y, Wang W, Cao W, Wang Y, Kushner SA, Peron JM, Alric L, et al. Hepatitis E virus infects neurons and brains. The Journal of Infectious Diseases. PMID 28199701 DOI: 10.1093/Infdis/Jix079 |
0.363 |
|
| 2017 |
Comarmond C, Garrido M, Desbois A, Costopoulos M, Le MG, Ahmed SS, Alric L, Fontaine H, Bellier B, Maciejewski A, Rosenzwajg M, Klatzmann D, Musset L, Poynard T, Cacoub P, et al. SAT0023 Direct-acting antiviral-based therapy restores immune tolerance in hepatitis c-induced cryoglobulinemia vasculitis Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2017-Eular.3911 |
0.357 |
|
| 2017 |
Halfon P, Scholtes C, Izopet J, Larrat S, Penaranda G, Trimoulet P, Zoulim F, Alric L, Metivier S, Bourliere M, Leroy V, Ouzan D, de Ledinghen V, Mohamed S, Thelu M, et al. Retreatment with Direct Active Antivirals of genotype 1, 3 and 4 chronic hepatitis C patients who previously failed an anti-NS5A-containing regimen in real world Journal of Hepatology. 66: S730-S731. DOI: 10.1016/S0168-8278(17)31949-9 |
0.422 |
|
| 2017 |
Protin C, Abravanel F, Laurent G, Tavitian S, Oberic L, Izopet J, Martin-Blondel G, Ysebaert L, Alric L. Hepatitis E virus infection and ribavirin treatment in patients with chronic lymphocytic leukemia receiving ibrutinib Journal of Hepatology. 66: S250. DOI: 10.1016/S0168-8278(17)30807-3 |
0.403 |
|
| 2017 |
Saadoun D, Pol S, Ferfar Y, Hezode C, Ahmed S, Alric L, de Saint Martin L, Bouyer A, Musset L, Poynard T, Rigon M, Cacoub P. Sofosbuvir plus daclatasvir for hepatitis C virus-cryoglobulinemia vasculitis (HCV-CryoVas): VASCUVALDIC 2 Study Journal of Hepatology. 66: S56-S57. DOI: 10.1016/S0168-8278(17)30375-6 |
0.419 |
|
| 2017 |
De Martin E, Coilly A, Houssel-Debry P, Ollivier-Hourmand I, Heurgue-Berlot A, Artru F, Barge S, Chazouilleres O, Silvain C, Duvoux C, Pageaux G, Besch C, Bourlière M, Fontaine H, de Ledinghen V, ... ... Alric L, et al. Treatment and prognosis of acute severe autoimmune hepatitis Journal of Hepatology. 66: S4. DOI: 10.1016/S0168-8278(17)30270-2 |
0.339 |
|
| 2017 |
Gordon SC, Gane E, Willems B, Roberts SA, Flamm SL, Bourliere M, Asselah T, Alric L, Letterio C, Llewellyn J, Hyland RH, Stamm L, Huang K, Brainard D, Khalili M, et al. The Safety and Tolerability of SOF/VEL/VOX for 8 or 12 Weeks in > 1,000 Patients Treated in the POLARIS-1, POLARIS-2, POLARIS-3, and POLARIS-4 Studies: An Integrated Analysis Gastroenterology. 152: S1088. DOI: 10.1016/S0016-5085(17)33668-5 |
0.327 |
|
| 2017 |
Merli M, Alric L, Mannelli L, De Angelis F, Ferrari A, Capecchi M, Pirisi M, Visco C, Piazza F, Loustaud-Ratti V, Goldaniga M, Zancanella M, Cencini E, Marino D, Benanti F, et al. DIRECT-ACTING ANTIVIRALS DURING OR AFTER IMMUNO-CHEMOTHERAPY IN HEPATITIS C VIRUS-ASSOCIATED DIFFUSE LARGE B-CELL LYMPHOMAS Hematological Oncology. 35: 194-196. DOI: 10.1002/Hon.2438_57 |
0.337 |
|
| 2017 |
Frigeni M, Visco C, Besson C, Rattotti S, Fontaine H, Goldaniga M, Visentini M, Torres HA, Peveling‐Oberhag J, Rossotti R, Zaja F, Rigacci L, Merli M, Dorival C, Alric L, et al. Interferon‐Free Antiviral Treatment In B‐Cell Lymphoproliferative Disorders Associated With Chronic Hepatitis‐C Virus Infection Hematological Oncology. 35: 145-146. DOI: 10.1002/Hon.2437_135 |
0.318 |
|
| 2016 |
Dumortier J, Bailly F, Pageaux GP, Vallet-Pichard A, Radenne S, Habersetzer F, Gagnieu MC, Grangé JD, Minello A, Guillaud O, Kamar N, Alric L, Leroy V. Sofosbuvir-based antiviral therapy in hepatitis C virus patients with severe renal failure. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. PMID 27760839 DOI: 10.1093/Ndt/Gfw348 |
0.433 |
|
| 2016 |
Alric L, Besson C, Lapidus N, Jeannel J, Michot JM, Cacoub P, Canioni D, Pol S, Davi F, Rabiega P, Ysebaert L, Bonnet D, Hermine O. Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study. Plos One. 11: e0162965. PMID 27749916 DOI: 10.1371/Journal.Pone.0162965 |
0.418 |
|
| 2016 |
Rostaing L, Alric L, Kamar N. Use of direct-acting agents for hepatitis C virus-positive kidney transplant candidates and kidney transplant recipients. Transplant International : Official Journal of the European Society For Organ Transplantation. 29: 1257-1265. PMID 27717014 DOI: 10.1111/Tri.12870 |
0.422 |
|
| 2016 |
Nahon P, Bourcier V, Layese R, Audureau E, Cagnot C, Marcellin P, Guyader D, Fontaine H, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, ... ... Alric L, et al. Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications. Gastroenterology. PMID 27641509 DOI: 10.1053/J.Gastro.2016.09.009 |
0.444 |
|
| 2016 |
Pol S, Bourliere M, Lucier S, Hezode C, Dorival C, Larrey D, Bronowicki JP, Ledinghen V, Zoulim F, Tran A, Metivier S, Zarski JP, Samuel D, Guyader D, Marcellin P, ... ... Alric L, et al. Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients. Journal of Hepatology. PMID 27622858 DOI: 10.1016/J.Jhep.2016.08.021 |
0.394 |
|
| 2016 |
Arcaini L, Besson C, Frigeni M, Fontaine H, Goldaniga M, Casato M, Visentini M, Torres HA, Loustaud-Ratti V, Peveling-Oberhag J, Fabris P, Rossotti R, Zaja F, Rigacci L, Rattotti S, ... ... Alric L, et al. Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection. Blood. PMID 27605512 DOI: 10.1182/Blood-2016-05-714667 |
0.439 |
|
| 2016 |
Fontaine H, Maynard M, Bouix C, Carrieri MP, Botta-Fridlund D, D'Alteroche L, Conti F, Pageaux GP, Leroy V, Métivier S, Anty R, Durand F, Canva V, Vilotitch A, Lebray P, ... Alric L, et al. Efficacy and safety of boceprevir-based triple therapy in HCV cirrhotic patients awaiting liver transplantation (ANRS HC29 BOCEPRETRANSPLANT). Clinics and Research in Hepatology and Gastroenterology. PMID 27554134 DOI: 10.1016/J.Clinre.2016.06.006 |
0.382 |
|
| 2016 |
Kamar N, Lhomme S, Abravanel F, Marion O, Peron JM, Alric L, Izopet J. Treatment of HEV Infection in Patients with a Solid-Organ Transplant and Chronic Hepatitis. Viruses. 8. PMID 27537905 DOI: 10.3390/V8080222 |
0.383 |
|
| 2016 |
Ganne-Carrié N, Layese R, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, de Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, ... ... Alric L, et al. Nomogram for individualized prediction of hepatocellular carcinoma occurrence in HCV-cirrhosis (ANRS CO12 CirVir). Hepatology (Baltimore, Md.). PMID 27348075 DOI: 10.1002/Hep.28702 |
0.351 |
|
| 2016 |
Sogni P, Gilbert C, Lacombe K, Piroth L, Rosenthal E, Miailhes P, Gervais A, Esterle L, Chas J, Poizot-Martin I, Dominguez S, Simon A, Morlat P, Neau D, Zucman D, ... ... Alric L, et al. All-oral DAA regimens in HIV-HCV coinfected cirrhotic patients are efficient and safe. Real-life results from the prospective ANRS CO13 - HEPAVIH cohort. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 27317796 DOI: 10.1093/Cid/Ciw379 |
0.361 |
|
| 2016 |
Canioni D, Michot JM, Rabiega P, Molina TJ, Charlotte F, Lazure T, Davi F, Settegrana C, Berger F, Alric L, Cacoub P, Terrier B, Suarez F, Sibon D, Dupuis J, et al. In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas. Plos One. 11: e0156384. PMID 27257992 DOI: 10.1371/Journal.Pone.0156384 |
0.394 |
|
| 2016 |
Poizot-Martin I, Bellissant E, Garraffo R, Colson P, Piroth L, Solas C, Renault A, Bourlière M, Halfon P, Ghosn J, Alric L, Naqvi A, Carrieri P, Molina JM. Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 study. Hiv Clinical Trials. 17: 63-71. PMID 27077673 DOI: 10.1080/15284336.2015.1135553 |
0.366 |
|
| 2016 |
Trémeaux P, Lhomme S, Chapuy-Regaud S, Peron JM, Alric L, Kamar N, Izopet J, Abravanel F. Performance of an antigen assay for diagnosing acute hepatitis E virus genotype 3 infection. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 79: 1-5. PMID 27038538 DOI: 10.1016/J.Jcv.2016.03.019 |
0.381 |
|
| 2016 |
Abravanel F, Barragué H, Dörr G, Sauné K, Péron JM, Alric L, Kamar N, Izopet J, Champagne E. Conventional and innate lymphocytes response at the acute phase of HEV infection in transplanted patients. The Journal of Infection. 72: 723-30. PMID 26947133 DOI: 10.1016/J.Jinf.2016.02.016 |
0.37 |
|
| 2016 |
Alric L, Bonnet D. Grazoprevir + elbasvir for the treatment of hepatitis C virus infection. Expert Opinion On Pharmacotherapy. 17: 735-42. PMID 26933896 DOI: 10.1517/14656566.2016.1161028 |
0.438 |
|
| 2016 |
Kamar N, Marion O, Rostaing L, Cointault O, Ribes D, Lavayssière L, Esposito L, Del Bello A, Métivier S, Barange K, Izopet J, Alric L. Efficacy and Safety of Sofosbuvir-Based Antiviral Therapy to Treat Hepatitis C Virus Infection After Kidney Transplantation. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 16: 1474-9. PMID 26587971 DOI: 10.1111/Ajt.13518 |
0.404 |
|
| 2016 |
Saadoun D, Thibault V, Si Ahmed SN, Alric L, Mallet M, Guillaud C, Izzedine H, Plaisier A, Fontaine H, Costopoulos M, Le Garff-Tavernier M, Hezode C, Pol S, Musset L, Poynard T, et al. Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study. Annals of the Rheumatic Diseases. 75: 1777-82. PMID 26567178 DOI: 10.1136/Annrheumdis-2015-208339 |
0.42 |
|
| 2016 |
Péron JM, Abravanel F, Guillaume M, Gérolami R, Nana J, Anty R, Pariente A, Renou C, Bureau C, Robic MA, Alric L, Vinel JP, Izopet J, Kamar N. Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study. Liver International : Official Journal of the International Association For the Study of the Liver. 36: 328-33. PMID 26179015 DOI: 10.1111/Liv.12911 |
0.382 |
|
| 2016 |
Moulis G, Comont T, Germain J, Essilini A, Brun N, Dingremont C, Castel B, Montané de la Roque P, Madaule S, Sailler L, Prudhomme L, Arista S, Balardy L, Gaches F, Hebraud B, ... ... Alric L, et al. Positivity Rates of Tests Used at Immune Thrombocytopenia Diagnosis to Detect Associated Diseases. a Prospective Multicenter Cohort Study of 218 Patients Blood. 128: 1367-1367. DOI: 10.1182/Blood.V128.22.1367.1367 |
0.319 |
|
| 2016 |
Vancassel M, Jurado C, Eyvrard F, Houet S, Watier M, Alric L, Metivier S, Abravanel F, Bagheri H, Bellon B. CP-146 Drug interactions with direct acting antivirals for hepatitis C: What about in practice? pharmaceutical impact European Journal of Hospital Pharmacy. 23: A64.2-A65. DOI: 10.1136/Ejhpharm-2016-000875.146 |
0.326 |
|
| 2016 |
Hézode C, Abergel A, Chas J, Conti F, Cotte L, Tateo M, Alric L, Vergniol J, Tomei C, Bernard P, Loustaud-Ratti V, Arpurt J, Blaison D, Larrey D, Fedchuk L, et al. Sustained Virologic Response to Daclatasvir and Sofosbuvir, with or without Ribavirin, among Patients in the French Daclatasvir ATU Programme Infected with HCV Genotypes 4, 5 and 6 Journal of Hepatology. 64: S755. DOI: 10.1016/S0168-8278(16)01471-9 |
0.408 |
|
| 2016 |
Bureau C, Thabut D, Layese R, Bourcier V, Corvy L, Petrov-Sanchez V, Marcellin P, Guyader D, Pol S, Larrey D, Zoulim F, Roulot D, De Ledinghen V, Ouzan D, Tran A, ... ... Alric L, et al. The Benefits of Virosuppression on Progression of Portal Hypertension in Patients with Compensated Viral Cirrhosis (ANRS CO12 CirVir Cohort) Journal of Hepatology. 64: S655-S656. DOI: 10.1016/S0168-8278(16)01228-9 |
0.308 |
|
| 2016 |
Pischke S, Von Felden J, Peron J, Alric L, Wedemeyer H, Spengler U, Schnitzler P, Bettinger D, Schlabe S, Cornelissen J, zu Siederdissen C, Giordani M, Par G, Thimme R, Lohse A, et al. Rheumatological Patients are at Risk of Chronic HEV Infection: A Multicentric European Study Journal of Hepatology. 64: S365-S366. DOI: 10.1016/S0168-8278(16)00544-4 |
0.309 |
|
| 2016 |
Von Felden J, Alric L, Schnitzler P, Bettinger D, Peron J, Wedemeyer H, Spengler U, Schlabe S, Hoener zu Siederdissen C, Cornelissen J, Giordani M, Par G, Aitken C, Thimme R, Lohse A, et al. Hepatitis E in Haematological Patients in Europe: A Multicentre Study Journal of Hepatology. 64: S365. DOI: 10.1016/S0168-8278(16)00543-2 |
0.365 |
|
| 2016 |
Allaire M, Bourcier V, Layese R, Corvi L, Petrov-Sanchez V, Marcellin P, Guyader D, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki J, Zarski J, ... ... Alric L, et al. Extrahepatic Cancer is the Second Cause of Non Liver-Related Death in Patients with Compensated Viral Cirrhosis and is Associated with Viral Replication (ANRS CO12 CirVir Prospective Cohort) Journal of Hepatology. 64: S273. DOI: 10.1016/S0168-8278(16)00319-6 |
0.323 |
|
| 2016 |
Thervet E, Fontaine H, Bonnemains V, Alric L, Boffa J, Mathurin P, Stengel B, Carrat F, Pol S, Wittkop L. Étude transversale des atteintes rénales dans la cohorte de patients infectés par la VHC (HepatherPrévalence) de l’insuffisance rénale chronique (IRC) et facteurs associés chez les patients mono-infectés par le virus de l’hépatite C (VHC) dans la cohorte ANR NéPhrologie & ThéRapeutique. 12: 399-400. DOI: 10.1016/J.Nephro.2016.07.112 |
0.307 |
|
| 2015 |
Nahon P, Lescat M, Layese R, Bourcier V, Talmat N, Allam S, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, ... ... Alric L, et al. Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort). Gut. PMID 26511797 DOI: 10.1136/Gutjnl-2015-310275 |
0.308 |
|
| 2015 |
Perrin HB, Cintas P, Abravanel F, Gérolami R, d'Alteroche L, Raynal JN, Alric L, Dupuis E, Prudhomme L, Vaucher E, Couzigou P, Liversain JM, Bureau C, Vinel JP, Kamar N, et al. Neurologic Disorders in Immunocompetent Patients with Autochthonous Acute Hepatitis E. Emerging Infectious Diseases. 21. PMID 26490255 DOI: 10.3201/Eid2111.141789 |
0.316 |
|
| 2015 |
Coilly A, Dumortier J, Botta-Fridlund D, Latournerie M, Leroy V, Pageaux GP, Agostini H, Giostra E, Moreno C, Roche B, Antonini TM, Guillaud O, Lebray P, Radenne S, Saouli AC, ... ... Alric L, et al. Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future? Plos One. 10: e0138091. PMID 26394142 DOI: 10.1371/Journal.Pone.0138091 |
0.43 |
|
| 2015 |
Abravanel F, Lhomme S, Chapuy-Regaud S, Peron JM, Alric L, Rostaing L, Kamar N, Izopet J. Performance of a new rapid test for detecting anti-hepatitis E virus immunoglobulin M in immunocompetent and immunocompromised patients. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 70: 101-4. PMID 26305830 DOI: 10.1016/J.Jcv.2015.07.302 |
0.344 |
|
| 2015 |
Mehawej M, Rostaing L, Alric L, Del Bello A, Izopet J, Kamar N. Boceprevir-Based Triple Antiviral Therapy for Chronic Hepatitis C Virus Infection in Kidney-Transplant Candidates. Journal of Transplantation. 2015: 159795. PMID 26257919 DOI: 10.1155/2015/159795 |
0.427 |
|
| 2015 |
Tavitian S, Peron JM, Huguet F, Kamar N, Abravanel F, Beyne-Rauzy O, Oberic L, Faguer S, Alric L, Roussel M, Gaudin C, Ysebaert L, Huynh A, Recher C. Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies. Emerging Infectious Diseases. 21: 1466-9. PMID 26197210 DOI: 10.3201/Eid2108.150199 |
0.42 |
|
| 2015 |
Bourlière M, Bronowicki JP, de Ledinghen V, Hézode C, Zoulim F, Mathurin P, Tran A, Larrey DG, Ratziu V, Alric L, Hyland RH, Jiang D, Doehle B, Pang PS, Symonds WT, et al. Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS). The Lancet. Infectious Diseases. 15: 397-404. PMID 25773757 DOI: 10.1016/S1473-3099(15)70050-2 |
0.419 |
|
| 2015 |
Trinchet JC, Bourcier V, Chaffaut C, Ait Ahmed M, Allam S, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, ... ... Alric L, et al. Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort). Hepatology (Baltimore, Md.). 62: 737-50. PMID 25678021 DOI: 10.1002/Hep.27743 |
0.425 |
|
| 2015 |
Kamar N, Rostaing L, Alric L, Peron JM, Izopet J. [Treatment of hepatitis E virus infection]. Presse Medicale (Paris, France : 1983). 44: 339-42. PMID 25639626 DOI: 10.1016/J.Lpm.2014.10.011 |
0.417 |
|
| 2015 |
Bailly F, Virlogeux V, Dufour C, Pradat P, Hézode C, Larrey D, Alric L, Samuel D, Bourlière M, Métivier S, Zarski JP, Fontaine H, Loustaud-Ratti V, Serfaty L, Bronowicki JP, et al. Early virological assessment during telaprevir- or boceprevir-based triple therapy in hepatitis C cirrhotic patients who failed a previous interferon based regimen - The ANRS CO20-CUPIC study. Clinics and Research in Hepatology and Gastroenterology. 39: 443-50. PMID 25636238 DOI: 10.1016/J.Clinre.2014.12.007 |
0.424 |
|
| 2015 |
Lawitz E, Gane E, Pearlman B, Tam E, Ghesquiere W, Guyader D, Alric L, Bronowicki JP, Lester L, Sievert W, Ghalib R, Balart L, Sund F, Lagging M, Dutko F, et al. Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial. Lancet. 385: 1075-86. PMID 25467591 DOI: 10.1016/S0140-6736(14)61795-5 |
0.424 |
|
| 2015 |
Michot JM, Canioni D, Driss H, Alric L, Cacoub P, Suarez F, Sibon D, Thieblemont C, Dupuis J, Terrier B, Feray C, Tilly H, Pol S, Leblond V, Settegrana C, et al. Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study. American Journal of Hematology. 90: 197-203. PMID 25417909 DOI: 10.1002/Ajh.23889 |
0.408 |
|
| 2015 |
Fontaine H, Maynard-Muet M, Bouix C, Botta-Fridlund D, D’Alteroche L, Conti F, Pageaux G, Leroy V, Métivier S, Anty R, Durand F, Canva V, Lebray P, Alric L, Duvoux C, et al. P0137 : Safety of boceprevir-based triple therapy in HCV cirrhotic patients awaiting liver transplantation. Analysis from a French multicenter, open-label study (ANRS HC29 bocepretransplant) Journal of Hepatology. 62: S352-S353. DOI: 10.1016/S0168-8278(15)30357-3 |
0.377 |
|
| 2015 |
Fontaine H, Hezode C, Zoulim F, Samuel D, Bourliere M, Haour G, Dorival-Mouly C, Leroy V, De Ledinghen V, Lucier S, Larrey D, Tran A, Metivier S, Benhamou Y, Hubert-Fouchard I, ... ... Alric L, et al. LP28 : Efficacy of the oral sofosbuvir-based combinations in HCV genotype 4-mono-infected patients from the french observational cohort anrs CO22 hepather Journal of Hepatology. 62: S278. DOI: 10.1016/S0168-8278(15)30182-3 |
0.38 |
|
| 2015 |
Pol S, Bourliere M, Lucier S, De Ledinghen V, Zoulim F, Dorival-Mouly C, Métivier S, Larrey D, Tran A, Hezode C, Bronowicki J, Samuel D, Marcellin P, Zarski J, Minello A, ... Alric L, et al. LO3 : Safety and efficacy of the combination daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients from the french observational cohort ANRS CO22 hepather* Journal of Hepatology. 62: S258-S259. DOI: 10.1016/S0168-8278(15)30149-5 |
0.374 |
|
| 2014 |
Geri G, Maynard M, Rosenthal E, Fontaine H, Lacombe K, Slama L, Goujard C, Loustaud-Ratti V, Bergmann JF, Morlat P, Vittecoq D, Alric L, Cacoub P, Pautard-Huchembl B, Schmit JL, et al. Care of hepatitis C virus infection in France: Modifications in three consecutive surveys between 1995 and 2010 Liver International. 34: 1349-1357. PMID 25368876 DOI: 10.1111/Liv.12388 |
0.45 |
|
| 2014 |
Bonnet D, Guivarch M, Bérard E, Combis JM, Remy AJ, Glibert A, Payen JL, Metivier S, Barange K, Desmorat H, Palacin A, Nicot F, Abravanel F, Alric L. Telaprevir- and boceprevir-based tritherapies in real practice for F3-F4 pretreated hepatitis C virus patients. World Journal of Hepatology. 6: 660-9. PMID 25276282 DOI: 10.4254/Wjh.V6.I9.660 |
0.405 |
|
| 2014 |
Rostaing L, Alric L, Izopet J, Kamar N. What are the management issues for hepatitis C in dialysis patients?: hepatitis C virus infection and its treatment in patients with end-stage renal disease. Seminars in Dialysis. 27: 451-5. PMID 25204878 DOI: 10.1111/Sdi.12290 |
0.398 |
|
| 2014 |
Zignego AL, Wojcik GL, Cacoub P, Visentini M, Casato M, Mangia A, Latanich R, Charles ED, Gragnani L, Terrier B, Piazzola V, Dustin LB, Khakoo SI, Busch MP, Lauer GM, ... ... Alric L, et al. Genome-wide association study of hepatitis C virus- and cryoglobulin-related vasculitis. Genes and Immunity. 15: 500-5. PMID 25030430 DOI: 10.1038/Gene.2014.41 |
0.32 |
|
| 2014 |
Hézode C, Fontaine H, Dorival C, Zoulim F, Larrey D, Canva V, De Ledinghen V, Poynard T, Samuel D, Bourliere M, Alric L, Raabe JJ, Zarski JP, Marcellin P, Riachi G, et al. Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis. Gastroenterology. 147: 132-142.e4. PMID 24704719 DOI: 10.1053/J.Gastro.2014.03.051 |
0.439 |
|
| 2014 |
Hézode C, Alric L, Brown A, Hassanein T, Rizzetto M, Buti M, Bourliere M, Thabut D, Molina E, Mcphee F, Liu Z, Yin P, Hughes E, Treitel M. 819Daclatasvir in Combination with Peginterferon Alfa-2a and Ribavirin for Treatment-Naive Patients with HCV Genotype 4 Infection: Phase 3 COMMAND-4 Results Open Forum Infectious Diseases. 1: S233-S233. DOI: 10.1093/Ofid/Ofu052.527 |
0.374 |
|
| 2013 |
Abravanel F, Chapuy-Regaud S, Lhomme S, Miedougé M, Peron JM, Alric L, Rostaing L, Kamar N, Izopet J. Performance of anti-HEV assays for diagnosing acute hepatitis E in immunocompromised patients. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 58: 624-8. PMID 24183927 DOI: 10.1016/J.Jcv.2013.10.003 |
0.348 |
|
| 2013 |
Comont T, Bonnet D, Sigur N, Gerdelat A, Legrand-Abravanel F, Kamar N, Alric L. [Acute hepatitis E infection associated with Guillain-Barré syndrome in an immunocompetent patient]. La Revue De Medecine Interne. 35: 333-6. PMID 24080239 DOI: 10.1016/J.Revmed.2013.05.005 |
0.377 |
|
| 2013 |
Hézode C, Fontaine H, Dorival C, Larrey D, Zoulim F, Canva V, de Ledinghen V, Poynard T, Samuel D, Bourlière M, Zarski JP, Raabe JJ, Alric L, Marcellin P, Riachi G, et al. Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890. Journal of Hepatology. 59: 434-41. PMID 23669289 DOI: 10.1016/J.Jhep.2013.04.035 |
0.381 |
|
| 2013 |
Abravanel F, Lhomme S, Dubois M, Peron JM, Alric L, Kamar N, Izopet J. Hepatitis E virus. Medecine Et Maladies Infectieuses. 43: 263-70. PMID 23608595 DOI: 10.1016/J.Medmal.2013.03.005 |
0.395 |
|
| 2013 |
Kamar N, Alric L, Izopet J, Rostaing L. Hepatitis C virus and kidney disease. Clinics and Research in Hepatology and Gastroenterology. 37: 328-33. PMID 23522570 DOI: 10.1016/J.Clinre.2013.02.010 |
0.407 |
|
| 2013 |
Abravanel F, Chapuy-Regaud S, Lhomme S, Dubois M, Peron JM, Alric L, Rostaing L, Kamar N, Izopet J. Performance of two commercial assays for detecting hepatitis E virus RNA in acute or chronic infections. Journal of Clinical Microbiology. 51: 1913-6. PMID 23515544 DOI: 10.1128/Jcm.00661-13 |
0.326 |
|
| 2013 |
Duggal P, Thio CL, Wojcik GL, Goedert JJ, Mangia A, Latanich R, Kim AY, Lauer GM, Chung RT, Peters MG, Kirk GD, Mehta SH, Cox AL, Khakoo SI, Alric L, et al. Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Annals of Internal Medicine. 158: 235-45. PMID 23420232 DOI: 10.7326/0003-4819-158-4-201302190-00003 |
0.378 |
|
| 2013 |
Canioni D, Michot JM, Settegrana C, Driss H, Rabiega P, Barthe Y, Alric L, Suarez F, Cacoub P, Sibon D, Thieblemont C, Tilly H, Haioun C, Felim A, NGuyen Khac F, et al. Histological Characteristics Of Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas. Results Of The French Lympho-C ANRS HC-13 Multicentric Study Of 133 Patients Blood. 122: 3005-3005. DOI: 10.1182/Blood.V122.21.3005.3005 |
0.39 |
|
| 2013 |
Coilly A, Dumortier J, Botta-Fridlund D, Latournerie M, Leroy V, Pageaux G, Giostra E, Moreno C, Roche B, Lebray P, Radenne S, Saouli A, Calmus Y, Alric L, Debette-Gratien M, et al. 1422 END OF TREATMENT RESPONSE AFTER PROTEASE INHIBITOR (PI)- BASED THERAPY FOR HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION: A MULTICENTRIC EUROPEAN EXPERIENCE Journal of Hepatology. 58: S572-S573. DOI: 10.1016/S0168-8278(13)61421-X |
0.337 |
|
| 2013 |
Alric L, Bonnet D, Palacin A, Th'ebault S, Peron J, Sigur N, Nicot F, Abravanel F, Kamar N. 1229 COMPARISON OF VIROLOGICAL RESPONSE BETWEEN RIBAVIRIN AND PEG-INTERFERON MONOTHERAPY DURING AUTOCHTONOUS CHRONIC HEPATITIS E VIRUS INFECTION Journal of Hepatology. 58: S499. DOI: 10.1016/S0168-8278(13)61230-1 |
0.403 |
|
| 2012 |
Abravanel F, Mansuy JM, Huynh A, Kamar N, Alric L, Peron JM, Récher C, Izopet J. Low risk of hepatitis E virus reactivation after haematopoietic stem cell transplantation. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 54: 152-5. PMID 22425538 DOI: 10.1016/J.Jcv.2012.02.015 |
0.375 |
|
| 2012 |
Bonnet D, Kamar N, Izopet J, Alric L. [Hepatitis E: an emerging disease]. La Revue De Medecine Interne. 33: 328-34. PMID 22405325 DOI: 10.1016/J.Revmed.2012.01.017 |
0.398 |
|
| 2012 |
Kamar N, Weclawiak H, Guilbeau-Frugier C, Legrand-Abravanel F, Cointault O, Ribes D, Esposito L, Cardeau-Desangles I, Guitard J, Sallusto F, Muscari F, Peron JM, Alric L, Izopet J, Rostaing L. Hepatitis E virus and the kidney in solid-organ transplant patients. Transplantation. 93: 617-23. PMID 22298032 DOI: 10.1097/Tp.0B013E318245F14C |
0.378 |
|
| 2012 |
Mavigner M, Cazabat M, Dubois M, L'Faqihi FE, Requena M, Pasquier C, Klopp P, Amar J, Alric L, Barange K, Vinel JP, Marchou B, Massip P, Izopet J, Delobel P. Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals. The Journal of Clinical Investigation. 122: 62-9. PMID 22156200 DOI: 10.1172/Jci59011 |
0.614 |
|
| 2012 |
Nana J, Borentain P, Anty R, Abravanel F, Bureau C, Robic M, Alric L, Colson P, Izopet J, Vinel J, Kamar N, Gérolami R, Peron J. 564 TREATMENT OF AUTOCHTHONOUS ACUTE HEPATITIS E IN IMMUNOCOMPETENT PATIENTS WITH SHORT TERM RIBAVIRIN: A MULTICENTRIC FRENCH EXPERIENCE Journal of Hepatology. 56: S224. DOI: 10.1016/S0168-8278(12)60577-7 |
0.338 |
|
| 2011 |
Larsen C, Chaix ML, Le Strat Y, Velter A, Gervais A, Aupérin I, Alric L, Duval X, Miailhes P, Pioche C, Pol S, Piroth L, Delarocque-Astagneau E. Gaining greater insight into HCV emergence in HIV-infected men who have sex with men: the HEPAIG Study. Plos One. 6: e29322. PMID 22216248 DOI: 10.1371/Journal.Pone.0029322 |
0.376 |
|
| 2011 |
Alric L, Bonnet D, Beynes-Rauzy O, Izopet J, Kamar N. Definitive clearance of a chronic hepatitis E virus infection with ribavirin treatment. The American Journal of Gastroenterology. 106: 1562-3. PMID 21811285 DOI: 10.1038/Ajg.2011.158 |
0.384 |
|
| 2011 |
Chevaliez S, Hézode C, Soulier A, Costes B, Bouvier-Alias M, Rouanet S, Foucher J, Bronowicki JP, Tran A, Rosa I, Mathurin P, Alric L, Leroy V, Couzigou P, Mallat A, et al. High-dose pegylated interferon-α and ribavirin in nonresponder hepatitis C patients and relationship with IL-28B genotype (SYREN trial). Gastroenterology. 141: 119-27. PMID 21439960 DOI: 10.1053/J.Gastro.2011.03.039 |
0.423 |
|
| 2011 |
Daudé M, Rostaing L, Sauné K, Lavayssière L, Basse G, Esposito L, Guitard J, Izopet J, Alric L, Kamar N. Tenofovir therapy in hepatitis B virus-positive solid-organ transplant recipients. Transplantation. 91: 916-20. PMID 21325995 DOI: 10.1097/Tp.0B013E3182100F59 |
0.32 |
|
| 2011 |
Nicot F, Alric L, Barange K, Métivier S, Dramard JM, Combis JM, Castan B, Meurisse JJ, Payen JL, Garipuy D, Desmorat H, Peron JM, Thebault S, Morin T, Renou C, et al. Influence of HCV genotype 1 subtypes on the virus response to PEG interferon alpha-2a plus ribavirin therapy. Journal of Medical Virology. 83: 437-44. PMID 21264864 DOI: 10.1002/Jmv.21976 |
0.411 |
|
| 2011 |
Peck-Radosavljevic M, Boletis J, Besisik F, Ferraz ML, Alric L, Samuel D, Messinger D, Tietz A, Cheinquer H. Low-dose peginterferon alfa-2a is safe and produces a sustained virologic response in patients with chronic hepatitis C and end-stage renal disease. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 9: 242-8. PMID 21056689 DOI: 10.1016/J.Cgh.2010.10.018 |
0.374 |
|
| 2011 |
Marcellin P, Vierling J, Alric L, Pirisi M, Tran A, Albrecht J, Brass C, Boparai N, Sniukiene V, Burroughs M. 452 EFFICACY AMONG NORTH AMERICAN AND EUROPEAN HCV GENOTYPE-1 TREATMENT-NAIVE AND PREVIOUS NON-RESPONDERS AND RELAPSERS TO PEGINTERFERON/RIBAVIRIN WHEN TREATED WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN Journal of Hepatology. 54: S184. DOI: 10.1016/S0168-8278(11)60454-6 |
0.365 |
|
| 2010 |
Piroth L, Larsen C, Binquet C, Alric L, Auperin I, Chaix ML, Dominguez S, Duval X, Gervais A, Ghosn J, Delarocque-Astagneau E, Pol S. Treatment of acute hepatitis C in human immunodeficiency virus-infected patients: the HEPAIG study. Hepatology (Baltimore, Md.). 52: 1915-21. PMID 21064156 DOI: 10.1002/Hep.23959 |
0.43 |
|
| 2010 |
Kamar N, Rostaing L, Abravanel F, Garrouste C, Lhomme S, Esposito L, Basse G, Cointault O, Ribes D, Nogier MB, Alric L, Peron JM, Izopet J. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection. Gastroenterology. 139: 1612-8. PMID 20708006 DOI: 10.1053/J.Gastro.2010.08.002 |
0.396 |
|
| 2010 |
Alric L, Bonnet D, Laurent G, Kamar N, Izopet J. Chronic hepatitis E virus infection: successful virologic response to pegylated interferon-alpha therapy. Annals of Internal Medicine. 153: 135-6. PMID 20547885 DOI: 10.7326/0003-4819-153-2-201007200-00256 |
0.386 |
|
| 2010 |
Haennig A, Bonnet D, Thebault S, Alric L. Infliximab-induced acute hepatitis during Crohn's disease therapy: absence of cross-toxicity with adalimumab. Gastroenterologie Clinique Et Biologique. 34: e7-8. PMID 20189334 DOI: 10.1016/J.Gcb.2010.01.016 |
0.315 |
|
| 2010 |
Besson C, Canioni D, Settegrana C, Driss H, Alric L, Feray C, Suarez F, Khac FNG, Merle-Beral H, Cacoub P, Davi F, Hermine O. Favourable Outcome of B-Cell Non Hodgkin Lymphomas Associated with Hepatitis C Virus - ANRS HC13 LYMPHO-C Observational Study Blood. 116: 3116-3116. DOI: 10.1182/Blood.V116.21.3116.3116 |
0.389 |
|
| 2010 |
Bronowicki J, Canva V, Tran A, Hilleret M, Pol S, Mainard M, Bourlière M, de Ledinghen V, Abergel A, Barange K, Ganne N, Cales P, Di Martino V, Goria O, Molina J, ... Alric L, et al. 246 ASSESSMENT OF PAROXETINE IN THE PREVENTION OF DEPRESSION IN PATIENTS WITH CHRONIC HEPATITIS C TREATED BY PEG-INTERFERON-RIBAVIRIN.: A DOUBLE-BLINDED, RANDOMIZED STUDY. ANRS HC18 PAROPEG Journal of Hepatology. 52: S104. DOI: 10.1016/S0168-8278(10)60248-6 |
0.364 |
|
| 2010 |
Nani A, Sogni P, Habersetzer F, Zarski JPH, Hezode C, Bourliere M, Poynard T, Marcellin P, Alric L, Loustaud-Ratti V, Tran A, Mathurin P, Buffet C, Ganne N, Larrey D, et al. 635 Efficacy and Safety of the Combination of Entecavir (ETV)-Tenofovir (TDF) in the Treatment of Chronic Hepatitis B (CHB): A Nationwide, Retrospective Study Gastroenterology. 138: S-793. DOI: 10.1016/S0016-5085(10)63655-4 |
0.312 |
|
| 2010 |
Bronowicki J, Canva V, Tran A, Hilleret M, Pol S, Maynard M, Bourliere M, de Ledinghen V, Abergel A, Barange K, Ganne N, Cales P, Goria O, Di Martino V, Molina J, ... Alric L, et al. 536 Assessment of Paroxetine in the Prevention of Depression in Patients With Chronic Hepatitis C Treated by PEG-Interferon Alpha Plus Ribavirin: A Multicentric, Double-Blinded, Randomized Study. ANRS HC18 Paropeg Gastroenterology. 138: S-790. DOI: 10.1016/S0016-5085(10)63639-6 |
0.358 |
|
| 2009 |
Legrand-Abravanel F, Colson P, Leguillou-Guillemette H, Alric L, Ravaux I, Lunel-Fabiani F, Bouviers-Alias M, Trimoulet P, Chaix ML, Hézode C, Foucher J, Fontaine H, Roque-Afonso AM, Gassin M, Schvoerer E, et al. Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy. Journal of Medical Virology. 81: 2029-35. PMID 19856464 DOI: 10.1002/Jmv.21583 |
0.411 |
|
| 2009 |
Martin-Blondel G, Gales A, Bernad J, Cuzin L, Delobel P, Barange K, Izopet J, Pipy B, Alric L. Low interleukin-10 production by monocytes of patients with a self-limiting hepatitis C virus infection. Journal of Viral Hepatitis. 16: 485-91. PMID 19302337 DOI: 10.1111/J.1365-2893.2009.01094.X |
0.676 |
|
| 2009 |
Alric L, Kamar N, Bonnet D, Danjoux M, Abravanel F, Lauwers-Cances V, Rostaing L. Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis. Transplant International : Official Journal of the European Society For Organ Transplantation. 22: 568-73. PMID 19196449 DOI: 10.1111/J.1432-2277.2009.00834.X |
0.349 |
|
| 2009 |
Besson C, Canioni D, Settegrana C, Driss H, Alric L, Cacoub P, Feray C, Suarez F, Khac FN, Merle-Beral H, Davi F, Hermine O. Clinico-Pathological Characteristics of B-Cell Non Hodgkins Lymphomas Associated with Hepatitis C Virus ANRS HC13 LYMPHO-C Observational Study. Blood. 114: 1927-1927. DOI: 10.1182/Blood.V114.22.1927.1927 |
0.422 |
|
| 2009 |
Alric L, Nicot F, Barange K, Métivier S, Dramard J, Combis J, Payen J, Desmorat H, Peron J, Thebault S, Morin T, Renou C, Saune K, Chatelut E, Izopet J. P.361 Influence de la concentration plasmatique de PegIFNa2a et de la ribavirinémie sur la réponse virologique précoce au cours de l’hépatite virale C GastroentéRologie Clinique Et Biologique. 33: A229. DOI: 10.1016/S0399-8320(09)73052-0 |
0.318 |
|
| 2009 |
Hézode C, Foucher J, Bronowicki J, Leroy V, Tran A, Larrey D, Mathurin P, Rosa I, Alric L, Dhalluin-Venier V, Nani A, Bouvier-Alias M, Rouanet S, Couzigou P, Mallat A, et al. 123 EFFICACY AND SAFETY OF AN INTENSIFIED REGIMEN OF PEGYLATED INTERFERON ALFA-2A PLUS RIBAVIRIN IN HCV GENOTYPE 1 NON-RESPONDERS: AN INTERIM ANALYSIS OF THE SYREN TRIAL Journal of Hepatology. 50: S50. DOI: 10.1016/S0168-8278(09)60125-2 |
0.339 |
|
| 2008 |
Mansuy JM, Abravanel F, Miedouge M, Mengelle C, Merviel C, Dubois M, Kamar N, Rostaing L, Alric L, Moreau J, Peron JM, Izopet J. Acute hepatitis E in south-west France over a 5-year period. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 44: 74-7. PMID 18993112 DOI: 10.1016/J.Jcv.2008.09.010 |
0.311 |
|
| 2008 |
Kamar N, Milioto O, Alric L, El Kahwaji L, Cointault O, Lavayssière L, Sauné K, Izopet J, Rostaing L. Entecavir therapy for adefovir-resistant hepatitis B virus infection in kidney and liver allograft recipients. Transplantation. 86: 611-4. PMID 18724232 DOI: 10.1097/Tp.0B013E3181806C8C |
0.361 |
|
| 2008 |
Canivet C, Böhler T, Galvani S, Péron JM, Muscari F, Alric L, Barange K, Salvayre R, Negre-Salvayre A, Durand D, Suc B, Izopet J, Thomsen M, Rostaing L, Kamar N. In vitro mitogen-stimulated T-cell from hepatitis C virus-positive liver transplantation candidates, increases T-cell activation markers and T-cell proliferation. Transplant Immunology. 19: 112-9. PMID 18503886 DOI: 10.1016/J.Trim.2008.03.001 |
0.413 |
|
| 2008 |
Kamar N, Izopet J, Alric L, Guilbeaud-Frugier C, Rostaing L. Hepatitis C virus-related kidney disease: an overview. Clinical Nephrology. 69: 149-60. PMID 18397713 DOI: 10.5414/CNP69149 |
0.301 |
|
| 2008 |
Peck-Radosavljevic M, Boletis J, Besisik F, Ferraz ML, Alric L, Samuel D, Messinger D, Cheinquer H. 999 LOW-DOSE PEGINTERFERON ALFA-2A (40KD) (PEGASYS®) TO TREAT HEPATITIS C-INFECTED, END-STAGE RENAL DISEASE PATIENTS UNDERGOING HAEMODIALYSIS: FINAL STUDY RESULTS Journal of Hepatology. 48: S374. DOI: 10.1016/S0168-8278(08)61001-6 |
0.345 |
|
| 2007 |
Sandres-Sauné K, Abravanel F, Nicot F, Peron JM, Alric L, Boineau J, Pasquier C, Izopet J. Detection and quantitation of HCV RNA using real-time PCR after automated sample processing. Journal of Medical Virology. 79: 1821-6. PMID 17935166 DOI: 10.1002/Jmv.21003 |
0.359 |
|
| 2007 |
Péron JM, Bureau C, Poirson H, Mansuy JM, Alric L, Selves J, Dupuis E, Izopet J, Vinel JP. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. Journal of Viral Hepatitis. 14: 298-303. PMID 17439518 DOI: 10.1111/J.1365-2893.2007.00858.X |
0.382 |
|
| 2007 |
Alric L, Thebault S, Selves J, Peron JM, Mejdoubi S, Fortenfant F, Vinel JP. Characterization of overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis according to antimitochondrial antibodies status. Gastroenterologie Clinique Et Biologique. 31: 11-6. PMID 17273127 DOI: 10.1016/S0399-8320(07)89322-5 |
0.317 |
|
| 2007 |
Thomas F, Nicot F, Sandres-Sauné K, Dubois M, Legrand-Abravanel F, Alric L, Peron JM, Pasquier C, Izopet J. Genetic diversity of HCV genotype 2 strains in south western France. Journal of Medical Virology. 79: 26-34. PMID 17133555 DOI: 10.1002/Jmv.20765 |
0.689 |
|
| 2007 |
Peck-Radosavljevic M, Boletis J, Besisik F, Lucia Ferra M, Alric L, Samuel D, Messinger D, Junker H, Cheinquer H. [628] USE OF LOW-DOSE PEGINTERFERON a-2a (40 kD) (PEGASYS®) TO TREAT HEPATITIS C-INFECTED END-STAGE RENAL DISEASE PATIENTS UNDERGOING HAEMODIALYSIS: INTERIM RESULTS FROM A RANDOMISED STUDY Journal of Hepatology. 46: S237-S238. DOI: 10.1016/S0168-8278(07)62226-0 |
0.344 |
|
| 2006 |
Boulestin A, Kamar N, Sandres-Sauné K, Alric L, Vinel JP, Rostaing L, Izopet J. Pegylation of IFN-alpha and antiviral activity. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 26: 849-53. PMID 17238827 DOI: 10.1089/Jir.2006.26.849 |
0.345 |
|
| 2006 |
Abergel A, Hezode C, Leroy V, Barange K, Bronowicki JP, Tran A, Alric L, Castera L, Bernard PH, Henquell C, Lafeuille H, Ughetto S, Darcha C, Chevallier M, Martineau N, et al. Peginterferon alpha-2b plus ribavirin for treatment of chronic hepatitis C with severe fibrosis: A multicentre randomized controlled trial comparing two doses of peginterferon alpha-2b Journal of Viral Hepatitis. 13: 811-820. PMID 17109680 DOI: 10.1111/J.1365-2893.2006.00768.X |
0.372 |
|
| 2006 |
Sène D, Pol S, Piroth L, Goujard C, Dellamonica P, Moussali J, Rey D, Loustaud-Ratti V, Alric L, Chousterman M, Borsa-Lebas F, Boucher O, Séréni D, Cacoub P. Hepatitis B virus-human immunodeficiency virus co-infection in France: a cross-sectional multicentre study. Epidemiology and Infection. 135: 409-16. PMID 16863601 DOI: 10.1017/S0950268806006947 |
0.378 |
|
| 2006 |
Péron JM, Mansuy JM, Récher C, Bureau C, Poirson H, Alric L, Izopet J, Vinel JP. Prolonged hepatitis E in an immunocompromised patient. Journal of Gastroenterology and Hepatology. 21: 1223-4. PMID 16824086 DOI: 10.1111/J.1440-1746.2006.04209.X |
0.364 |
|
| 2006 |
Péron JM, Mansuy JM, Poirson H, Bureau C, Dupuis E, Alric L, Izopet J, Vinel JP. Hepatitis E is an autochthonous disease in industrialized countries. Analysis of 23 patients in South-West France over a 13-month period and comparison with hepatitis A. GastroentéRologie Clinique Et Biologique. 30: 757-62. PMID 16801899 DOI: 10.1016/S0399-8320(06)73310-3 |
0.395 |
|
| 2006 |
Kamar N, Rostaing L, Alric L. Treatment of hepatitis C-virus-related glomerulonephritis. Kidney International. 69: 436-9. PMID 16514428 DOI: 10.1038/Sj.Ki.5000142 |
0.427 |
|
| 2006 |
Alric L, Thebault S, Peron JM, Balard P, Metivier S, Pipy B, Izopet J, Vinel JP. Pilot study of interferon-alpha-ribavirin-interleukin-2 for treatment of nonresponder patients with severe liver disease infected by hepatitis C virus genotype 1. Journal of Viral Hepatitis. 13: 139-44. PMID 16436132 DOI: 10.1111/J.1365-2893.2005.00694.X |
0.793 |
|
| 2006 |
Boulestin A, Kamar N, Sandres-Sauné K, Legrand-Abravanel F, Alric L, Vinel JP, Rostaing L, Izopet J. Twenty-four hour kinetics of hepatitis C virus and antiviral effect of alpha-interferon. Journal of Medical Virology. 78: 365-71. PMID 16419107 DOI: 10.1002/Jmv.20548 |
0.426 |
|
| 2006 |
Balard P, José B, Maryse B, Carrera G, Lepert J, Alric L, Pipy B. P.429 HCV core protein activates peroxisome proliferator-activated receptor gamma (PPARγ) in human monocytes and regulates gene expression involved in M2 polarisation Journal of Clinical Virology. 36: S193-S194. DOI: 10.1016/S1386-6532(06)80602-5 |
0.782 |
|
| 2006 |
Péron J, Poirson H, Bureau C, Mansuy J, Selves J, Alric L, Métivier S, Dupuis E, Izopet J, Vinel J. 153 Acute hepato-cellular failure with encephalopathy in French patients with autochthonous acute sporadic hepatitis E Journal of Hepatology. 44: S65. DOI: 10.1016/S0168-8278(06)80154-6 |
0.315 |
|
| 2005 |
Kamar N, Rostaing L, Selves J, Sandres-Saune K, Alric L, Durand D, Izopet J. [The evolution of the hypervariable region-1 of hepatitis C virus may predict liver fibrosis outcome after renal transplantation]. Nã©Phrologie & Thã©Rapeutique. 1: 345-54. PMID 16895705 DOI: 10.1016/J.Nephro.2005.08.005 |
0.402 |
|
| 2005 |
Boulestin A, Sandres-Saune K, Alric L, Pipy B, Dubois M, Vinel JP, Izopet J. Evolution of hepatitis C virus quasispecies during therapy with IL2 combinated to alpha interferon and ribavirin. Antiviral Therapy. 10: 499-504. PMID 16038475 |
0.606 |
|
| 2005 |
Legrand-Abravanel F, Nicot F, Boulestin A, Sandres-Sauné K, Vinel JP, Alric L, Izopet J. Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection. Journal of Medical Virology. 77: 66-9. PMID 16032749 DOI: 10.1002/Jmv.20414 |
0.437 |
|
| 2005 |
Kamar N, Rostaing L, Sandres-Saune K, Selves J, Barthe C, Dubois M, Alric L, Durand D, Izopet J. Intrahepatic cytokine profile in renal-transplant patients infected by hepatitis C virus. Journal of Medical Virology. 76: 482-8. PMID 15977245 DOI: 10.1002/Jmv.20387 |
0.389 |
|
| 2005 |
Kamar N, Izopet J, Alric L, Rostaing L. Lack of evidence for ribavirin monotherapy efficacy on liver fibrosis in hepatitis C virus positive renal transplant patients. Transplantation. 79: 1770-1; author reply. PMID 15973189 DOI: 10.1097/01.Tp.0000158279.29506.E0 |
0.366 |
|
| 2005 |
Orfila C, Lepert JC, Alric L, Carrera G, Béraud M, Pipy B. Immunohistochemical distribution of activated nuclear factor kappaB and peroxisome proliferator-activated receptors in carbon tetrachloride-induced chronic liver injury in rats. Histochemistry and Cell Biology. 123: 585-93. PMID 15959796 DOI: 10.1007/S00418-005-0785-2 |
0.598 |
|
| 2005 |
Kamar N, Rostaing L, Selves J, Sandres-Saune K, Alric L, Durand D, Izopet J. Natural history of hepatitis C virus-related liver fibrosis after renal transplantation. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 5: 1704-12. PMID 15943629 DOI: 10.1111/J.1600-6143.2005.00918.X |
0.398 |
|
| 2005 |
Cacoub P, Goderel I, Morlat P, Sene D, Myers RP, Alric L, Loustaud-Ratti V, Melin P, Limal N, Ouzan D, Perronne C, Carrat F, Amir A, Andre P, Arlaund J, et al. Management of chronic hepatitis C in French departments of internal medicine and infectious diseases Epidemiology and Infection. 133: 305-314. PMID 15816156 DOI: 10.1017/S0950268804003486 |
0.436 |
|
| 2005 |
Nicot F, Legrand-Abravanel F, Sandres-Saune K, Boulestin A, Dubois M, Alric L, Vinel JP, Pasquier C, Izopet J. Heterogeneity of hepatitis C virus genotype 4 strains circulating in south-western France. The Journal of General Virology. 86: 107-14. PMID 15604436 DOI: 10.1099/Vir.0.80409-0 |
0.69 |
|
| 2004 |
Mansuy JM, Peron JM, Abravanel F, Poirson H, Dubois M, Miedouge M, Vischi F, Alric L, Vinel JP, Izopet J. Hepatitis E in the south west of France in individuals who have never visited an endemic area. Journal of Medical Virology. 74: 419-24. PMID 15368508 DOI: 10.1002/Jmv.20206 |
0.37 |
|
| 2004 |
Boulestin A, Kamar N, Legrand-Abravanel F, Sandres-Saune K, Alric L, Vinel JP, Rostaing L, Izopet J. Convenient biological assay for polyethylene glycol-interferons in patients with hepatitis C. Antimicrobial Agents and Chemotherapy. 48: 3610-2. PMID 15328140 DOI: 10.1128/Aac.48.9.3610-3612.2004 |
0.308 |
|
| 2004 |
Legrand-Abravanel F, Sandres-Sauné K, Barange K, Alric L, Moreau J, Desmorat P, Vinel JP, Izopet J. Hepatitis C virus genotype 5: epidemiological characteristics and sensitivity to combination therapy with interferon-alpha plus ribavirin. The Journal of Infectious Diseases. 189: 1397-400. PMID 15073676 DOI: 10.1086/382544 |
0.439 |
|
| 2004 |
Kamar N, Rostaing L, Alric L. [Hepatitis C virus and renal transplantation]. Gastroenterologie Clinique Et Biologique. 28: 120-5. PMID 15060455 DOI: 10.1016/S0399-8320(04)94864-6 |
0.329 |
|
| 2004 |
Alric L, Plaisier E, Thébault S, Péron JM, Rostaing L, Pourrat J, Ronco P, Piette JC, Cacoub P. Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 43: 617-23. PMID 15042538 DOI: 10.1053/J.Ajkd.2003.11.020 |
0.425 |
|
| 2004 |
Mansuy JM, Peron JM, Bureau C, Alric L, Vinel JP, Izopet J. Immunologically silent autochthonous acute hepatitis E virus infection in France. Journal of Clinical Microbiology. 42: 912-3. PMID 14766888 DOI: 10.1128/Jcm.42.2.912-913.2004 |
0.369 |
|
| 2004 |
Kamar N, Selves J, Sandres-Saune K, Alric L, Durand D, Izopet J, Rostaing L. EVOLUTION OF THE HYPERVARIABLE REGION-1 OF HEPATITIS C VIRUS AND LIVER FIBROSIS PROGRESSION IN RENAL-TRANSPLANT RECIPIENTS Transplantation. 78: 479. DOI: 10.1097/00007890-200407271-01289 |
0.334 |
|
| 2003 |
Carrera G, Paternain JL, Carrere N, Folch J, Courtade-Saïdi M, Orfila C, Vinel JP, Alric L, Pipy B. Hepatic metallothionein in patients with chronic hepatitis C: relationship with severity of liver disease and response to treatment. The American Journal of Gastroenterology. 98: 1142-9. PMID 12809840 DOI: 10.1111/J.1572-0241.2003.07403.X |
0.801 |
|
| 2003 |
POIRSON H, PERON J, ALRIC L, BUREAU C, METIVIER S, DUPUIS E, IZOPET J, VINEL J. 1067 Acute hepatitis E: a study of 17 consecutive patients in South-West France over a 13 month period Hepatology. 38: 670-670. DOI: 10.1016/S0270-9139(03)81105-9 |
0.349 |
|
| 2003 |
ALRIC L, IZOPET J, METIVIER S, TKACZUCK J, PIPY B, VINEL J. 334 HC07 ANRS trial - pilot study of triple therapy by recombinant interferona2A- ribavirin- IL-2 for treatment of nonresponder patients with severe liver disease infected by hepatitis C virus (HCV) genotype 1 Hepatology. 38: 320-320. DOI: 10.1016/S0270-9139(03)80377-4 |
0.655 |
|
| 2003 |
Alric L, Izopet J, Métivier S, Théult S, Tkaczuk J, Pipy B, Vinel J, Duffaut M. Essai RIFIL2-ANRS HC07: Étude pilote au coursde l'hépatite chronique virale C de l'efficacité d'une trithérapie par interleukine-2-intérferonα2a-ribavirine chez les patients infectés par un génotype 1 non répondeurs à une bithérapie par IFN-ribavirine avec des lésions histologiques modérées à sévères La Revue De MéDecine Interne. 24: 57s. DOI: 10.1016/S0248-8663(03)80079-6 |
0.6 |
|
| 2003 |
Carrera G, Paternain JL, Carrere N, Folch J, Courtade-Saïdi M, Orfila C, Vinel JP, Alric L, Pipy B. Original contributionHepatic metallothionein in patients with chronic hepatitis C: relationship with severity of liver disease and response to treatment The American Journal of Gastroenterology. 98. DOI: 10.1016/S0002-9270(03)00107-2 |
0.674 |
|
| 2002 |
Bureau C, Péron JM, Alric L, Morales J, Sanchez J, Barange K, Payen JL, Vinel JP. "A La Carte" treatment of portal hypertension: Adapting medical therapy to hemodynamic response for the prevention of bleeding. Hepatology (Baltimore, Md.). 36: 1361-6. PMID 12447860 DOI: 10.1002/Hep.1840360611 |
0.319 |
|
| 2002 |
Alric L, Di-Martino V, Selves J, Cacoub P, Charlotte F, Reynaud D, Piette JC, Péron JM, Vinel JP, Durand D, Izopet J, Poynard T, Duffaut M, Rostaing L. Long-term impact of renal transplantation on liver fibrosis during hepatitis C virus infection. Gastroenterology. 123: 1494-9. PMID 12404224 DOI: 10.1053/Gast.2002.36610 |
0.403 |
|
| 2002 |
Renou C, Halfon P, Pol S, Cacoub P, Jouve E, Bronowicki JP, Arpurt JP, Rifflet H, Picon M, Causse X, Canva V, Denis J, Tran A, Bourliére M, Ouzan D, ... ... Alric L, et al. Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels. Gut. 51: 585-90. PMID 12235085 DOI: 10.1136/Gut.51.4.585 |
0.429 |
|
| 2002 |
Dubourdeau M, Miyamura T, Matsuura Y, Alric L, Pipy B, Rousseau D. Infection of HepG2 cells with recombinant adenovirus encoding the HCV core protein induces p21(WAF1) down-regulation -- effect of transforming growth factor beta. Journal of Hepatology. 37: 486-92. PMID 12217602 DOI: 10.1016/S0168-8278(02)00241-6 |
0.774 |
|
| 2002 |
Boulestin A, Sandres-Sauné K, Payen JL, Alric L, Dubois M, Pasquier C, Vinel JP, Pascal JP, Puel J, Izopet J. Genetic heterogeneity of the envelope 2 gene and eradication of hepatitis C virus after a second course of interferon-α Journal of Medical Virology. 68: 221-228. PMID 12210411 DOI: 10.1002/Jmv.10192 |
0.683 |
|
| 2002 |
Alric L, Costedoat N, Piette JC, Duffaut M, Cacoub P. [Hepatitis C and pregnancy]. La Revue De Medecine Interne. 23: 283-91. PMID 11928376 DOI: 10.1016/S0248-8663(01)00553-7 |
0.384 |
|
| 2001 |
Alric L, Duffaut M, Selves J, Sandre K, Mularczyck M, Izopet J, Desmorat H, Bureau C, Chaouche N, Dalbergue B, Vinel JP. Maintenance therapy with gradual reduction of the interferon dose over one year improves histological response in patients with chronic hepatitis C with biochemical response: results of a randomized trial. Journal of Hepatology. 35: 272-8. PMID 11580151 DOI: 10.1016/S0168-8278(01)00110-6 |
0.801 |
|
| 2001 |
Bureau C, Bernad J, Chaouche N, Orfila C, Béraud M, Gonindard C, Alric L, Vinel JP, Pipy B. Nonstructural 3 protein of hepatitis C virus triggers an oxidative burst in human monocytes via activation of NADPH oxidase. The Journal of Biological Chemistry. 276: 23077-83. PMID 11304537 DOI: 10.1074/Jbc.M100698200 |
0.775 |
|
| 2001 |
Alric L, Orfila C, Carrere N, Beraud M, Carrera G, Lepert JC, Duffaut M, Pipy B, Vinel JP. Reactive oxygen intermediates and eicosanoid production by kupffer cells and infiltrated macrophages in acute and chronic liver injury induced in rats by CCl4. Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]. 49: 700-7. PMID 11211921 DOI: 10.1007/s000110050649 |
0.554 |
|
| 2001 |
Renou C, Halfon P, Pol S, Jouve E, Bronowiki J, Arpurt J, Rifflet H, Cacoub P, Picon M, Causse X, Canva V, Denis J, Tran A, Dantin S, Bourliere M, ... ... Alric L, et al. HLA class II alleles and histological features in chronically infected HCV patients with consistently normal ALT levels Journal of Hepatology. 34: 114. DOI: 10.1016/S0168-8278(01)81286-1 |
0.354 |
|
| 2000 |
Alric L, Partensky J, Reynaud D, Rauzy O, Duffaut M. [Association between polymyositis and hepatitis C infection. Treatment-related difficulties]. La Revue De Medecine Interne. 21: 542-6. PMID 10909154 DOI: 10.1016/S0248-8663(00)89230-9 |
0.401 |
|
| 2000 |
Orfila C, Lepert JC, Alric L, Carrera G, Beraud M, Vinel JP, Pipy B. Expression of TNF-alpha and immunohistochemical distribution of hepatic macrophage surface markers in carbon tetrachloride-induced chronic liver injury in rats. The Histochemical Journal. 31: 677-85. PMID 10576417 DOI: 10.1023/A:1003851821487 |
0.589 |
|
| 1999 |
Alric L, Izopet J, Fort M, Vinel JP, Fontenelle P, Orfila C, Payen JL, Sandres K, Desmorat H, Charlet JP, Duffaut M, Abbal M. Study of the association between major histocompatibility complex class II genes and the response to interferon alpha in patients with chronic hepatitis C infection. Human Immunology. 60: 516-23. PMID 10408801 DOI: 10.1016/S0198-8859(99)00021-X |
0.353 |
|
| 1999 |
Alric L, Fort M, Izopet J, Vinel JP, Duffaut M, Abbal M. Association between genes of the major histocompatibility complex class II and the outcome of hepatitis C virus infection. The Journal of Infectious Diseases. 179: 1309-10. PMID 10191244 DOI: 10.1086/314739 |
0.336 |
|
| 1999 |
Rostaing L, Izopet J, Arnaud C, Cisterne JM, Alric L, Rumeau JL, Duffaut M, Durand D. Long-term impact of superinfection by hepatitis G virus in hepatitis C virus-positive renal transplant patients. Transplantation. 67: 556-60. PMID 10071027 DOI: 10.1097/00007890-199902270-00012 |
0.438 |
|
| 1998 |
Izopet J, Payen JL, Alric L, Sandres K, Charlet JP, Vinel JP, Duffaut M, Pascal JP, Puel J. Baseline level and early suppression of serum HCV RNA for predicting sustained complete response to alpha-interferon therapy. Journal of Medical Virology. 54: 86-91. PMID 9496364 DOI: 10.1002/(Sici)1096-9071(199802)54:2<86::Aid-Jmv3>3.0.Co;2-K |
0.402 |
|
| 1998 |
Izopet J, Rostaing L, Moussion F, Alric L, Dubois M, That HT, Payen JL, Duffaut M, Durand D, Suc JM, Puel J. High rate of hepatitis C virus clearance in hemodialysis patients after interferon-alpha therapy. The Journal of Infectious Diseases. 176: 1614-7. PMID 9395376 DOI: 10.1086/517339 |
0.431 |
|
| 1998 |
Nival-Anacréon S, Alric L, Reynaud D, Mularczyck M, Selves J, Vinel J, Pascal J, Duffaut M. Complications de la cirrhose virale C: étude d'une cohorte de 82 patients La Revue De MéDecine Interne. 19: 94S. DOI: 10.1016/S0248-8663(98)80139-2 |
0.307 |
|
| 1998 |
Reynaud D, Alric L, Selves J, Rostaing L, Rumeau J, Izopet J, Duffaut M. Évolution des lésions anatomopathologiques hépatiques chez les patients transplantés rénaux infectés par le virus de l'hépatite C La Revue De MéDecine Interne. 19: 93S. DOI: 10.1016/S0248-8663(98)80138-0 |
0.31 |
|
| 1997 |
Bonnet E, Massip P, Bauriaud R, Alric L, Auvergnat JC. Disseminated Mycobacterium gordonae infection in a patient infected with human immunodeficiency virus. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 23: 644-5. PMID 8879799 DOI: 10.1093/Clinids/23.3.644 |
0.319 |
|
| 1996 |
Alric L, Pinelli E, Carrera G, Vinel JP, Beraud M, Duffaut M, Pascal JP, Pipy B. Involvement of calcium in macrophage leukotriene release during experimental cirrhosis. Hepatology (Baltimore, Md.). 23: 614-22. PMID 8617444 DOI: 10.1002/Hep.510230329 |
0.695 |
|
| Show low-probability matches. |